News

Pharmabiz18h
Clearmind Medicine gets IRB nod from TASMC for phase 1/2a clinical trial to evaluate CMND-100 for treatment of alcohol use disorder
Clearmind Medicine gets IRB nod from TASMC for phase 1/2a clinical trial to evaluate CMND-100 for treatment of alcohol use disorder: Vancouver, Canada Saturday, July 5, 2025, 18:0 ...
Pharmabiz19h
Dyadic International announces strategic rebrand to Dyadic Applied BioSolutions
Dyadic International announces strategic rebrand to Dyadic Applied BioSolutions: Jupiter, Florida Saturday, July 5, 2025, 17:00 Hrs [IST] Dyadic International, Inc, a global biote ...
Pharmabiz20h
Thermo Fisher Scientific’s NGS assay, Oncomine Dx Express Test receives US FDA approval as a companion diagnostic for Dizal’s Zegfrovy
Carlsbad, California Saturday, July 5, 2025, 16:00 Hrs [IST] ...
Pharmabiz21h
Theratechnologies signs binding arrangement agreement with CB Biotechnology to buy all issued and outstanding common shares of the company
Theratechnologies signs binding arrangement agreement with CB Biotechnology to buy all issued and outstanding common shares of the company: Montreal Saturday, July 5, 2025, 15:00 ...
Pharmabiz22h
Ensem Therapeutics doses first patient in phase 1/2 clinical study of ETX-636, a novel allosteric pan-mutant-selective PI3Ka inhibitor and degrader
Ensem Therapeutics doses first patient in phase 1/2 clinical study of ETX-636, a novel allosteric pan-mutant-selective PI3Ka inhibitor and degrader: Waltham, Massachusetts Saturda ...
Pharmabiz23h
Invivyd, SPEAR Study Group to assess the effects of monoclonal antibody therapy for recent Covid & Covid-19 post-vaccination syndrome
Invivyd, SPEAR Study Group to assess the effects of monoclonal antibody therapy for recent Covid & Covid-19 post-vaccination syndrome: Waltham, Massachusetts Saturday, July 5, 202 ...
Pharmabiz1d
Onward Medical submits two major regulatory applications for its ARC-EX system; seeking clearance to expand its indication for home use
Onward Medical submits two major regulatory applications for its ARC-EX system; seeking clearance to expand its indication for home use: Eindhoven, the Netherlands Saturday, July ...